Zyban (Bupropion Hydrochloride)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
June 2016
ADVERSE REACTIONS
Postmarketing Experience
Nervous System
(recategorizing some adverse effects under a single...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts